Breast Cancer Survivors Who Experience Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS): A Multidisciplinary Pain Program Designed to Decrease Pain and Improve Functioning, Mood, and Medication Adherence

Inclusion Criteria

• * Patients are 18 years old or more. * A breast cancer survivor ECOG =< 2, stage 0-III HR+ who is experiencing musculoskeletal symptoms associated with aromatase inhibitors intake * Patients must be at least 6 months on aromatase inhibitors and for no more than 7 year

Exclusion Criteria

• * Breast cancer survivor patients that are not in aromatase inhibitor’s treatment or has less than 6 months of treatment or more than 7 years of treatment. * Asymptomatic patients * Patient has less than 18 years old * Patient that are not being followed as a Mayo Clinic patient • Patients with stage IV breast carcinoma • Patients that are HR – • Patients that are ECOG 3 or more